BIOMAT Database Logo BIOMAT Database Logo

[Mechanisms of the protective effect of yeast RNA in experimental bacterial infections]. 1974

V M Zemskov, and V M Shilov, and N I Tsyganova, and N I Korabel'nikova, and L L Fadeeva

UI MeSH Term Description Entries
D007109 Immunity Nonsusceptibility to the invasive or pathogenic effects of foreign microorganisms or to the toxic effect of antigenic substances. Immune Process,Immune Response,Immune Processes,Immune Responses,Process, Immune,Response, Immune
D007369 Interferon Inducers Agents that promote the production and release of interferons. They include mitogens, lipopolysaccharides, and the synthetic polymers Poly A-U and Poly I-C. Viruses, bacteria, and protozoa have been also known to induce interferons. Inducers, Interferon
D007372 Interferons Proteins secreted by vertebrate cells in response to a wide variety of inducers. They confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions. Interferon
D009113 Muramidase A basic enzyme that is present in saliva, tears, egg white, and many animal fluids. It functions as an antibacterial agent. The enzyme catalyzes the hydrolysis of 1,4-beta-linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in peptidoglycan and between N-acetyl-D-glucosamine residues in chitodextrin. EC 3.2.1.17. Lysozyme,Leftose,N-Acetylmuramide Glycanhydrolase,Glycanhydrolase, N-Acetylmuramide,N Acetylmuramide Glycanhydrolase
D010586 Phagocytes Cells that can carry out the process of PHAGOCYTOSIS. Phagocyte,Phagocytic Cell,Phagocytic Cells,Cell, Phagocytic,Cells, Phagocytic
D010587 Phagocytosis The engulfing and degradation of microorganisms; other cells that are dead, dying, or pathogenic; and foreign particles by phagocytic cells (PHAGOCYTES). Phagocytoses
D011414 Properdin A 53-kDa protein that is a positive regulator of the alternate pathway of complement activation (COMPLEMENT ACTIVATION PATHWAY, ALTERNATIVE). It stabilizes the ALTERNATIVE PATHWAY C3 CONVERTASE (C3bBb) and protects it from rapid inactivation, thus facilitating the cascade of COMPLEMENT ACTIVATION and the formation of MEMBRANE ATTACK COMPLEX. Individuals with mutation in the PFC gene exhibit properdin deficiency and have a high susceptibility to infections. Complement Factor P,Factor P, Complement
D001770 Blood Bactericidal Activity The natural bactericidal property of BLOOD due to normally occurring antibacterial substances such as beta lysin, leukin, etc. This activity needs to be distinguished from the bactericidal activity contained in a patient's serum as a result of antimicrobial therapy, which is measured by a SERUM BACTERICIDAL TEST. Activities, Blood Bactericidal,Activity, Blood Bactericidal,Bactericidal Activities, Blood,Bactericidal Activity, Blood,Blood Bactericidal Activities
D002452 Cell Count The number of CELLS of a specific kind, usually measured per unit volume or area of sample. Cell Density,Cell Number,Cell Counts,Cell Densities,Cell Numbers,Count, Cell,Counts, Cell,Densities, Cell,Density, Cell,Number, Cell,Numbers, Cell
D002642 Chick Embryo The developmental entity of a fertilized chicken egg (ZYGOTE). The developmental process begins about 24 h before the egg is laid at the BLASTODISC, a small whitish spot on the surface of the EGG YOLK. After 21 days of incubation, the embryo is fully developed before hatching. Embryo, Chick,Chick Embryos,Embryos, Chick

Related Publications

V M Zemskov, and V M Shilov, and N I Tsyganova, and N I Korabel'nikova, and L L Fadeeva
[Protective effect of the mushroom polysaccharide Schizophyllan against experimental bacterial infections].
June 1973, The Japanese journal of antibiotics,
V M Zemskov, and V M Shilov, and N I Tsyganova, and N I Korabel'nikova, and L L Fadeeva
[Bacterial infections and protective mechanisms of the host].
January 1986, Rinsho byori. The Japanese journal of clinical pathology,
V M Zemskov, and V M Shilov, and N I Tsyganova, and N I Korabel'nikova, and L L Fadeeva
[Protective effect of human gamma globulin preparations on experimental bacterial infections in mice].
December 1982, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
V M Zemskov, and V M Shilov, and N I Tsyganova, and N I Korabel'nikova, and L L Fadeeva
[Protective effect of Prodigiozan in experimental infections].
August 1966, Biulleten' eksperimental'noi biologii i meditsiny,
V M Zemskov, and V M Shilov, and N I Tsyganova, and N I Korabel'nikova, and L L Fadeeva
Protective effects of pidotimod against experimental bacterial infections in mice.
December 1994, Arzneimittel-Forschung,
V M Zemskov, and V M Shilov, and N I Tsyganova, and N I Korabel'nikova, and L L Fadeeva
[Protective effect of cellular immunity in experimental Flavivirus infections].
September 1977, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
V M Zemskov, and V M Shilov, and N I Tsyganova, and N I Korabel'nikova, and L L Fadeeva
Effect of bacterial endotoxin on experimental fungal infections.
January 1968, Journal of immunology (Baltimore, Md. : 1950),
V M Zemskov, and V M Shilov, and N I Tsyganova, and N I Korabel'nikova, and L L Fadeeva
[Experimental bacterial infections].
January 1972, Nihon rinsho. Japanese journal of clinical medicine,
V M Zemskov, and V M Shilov, and N I Tsyganova, and N I Korabel'nikova, and L L Fadeeva
[The effect of yeast RNA on the outcome of experimental infection in mice].
August 1969, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
V M Zemskov, and V M Shilov, and N I Tsyganova, and N I Korabel'nikova, and L L Fadeeva
[Summermastitis--the possible protective effect of two vaccines against experimental infections].
May 1972, Nordisk veterinaermedicin,
Copied contents to your clipboard!